Related Experiment Videos
Thin basement membrane nephropathy associated with other glomerular diseases.
Suzanne M Norby1, Fernando G Cosio
1Department of Internal Medicine, Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA.
Seminars in Nephrology
|May 10, 2005
Summary
Thin basement membrane nephropathy (TBMN) often co-occurs with other kidney diseases. While TBMN may worsen prognosis, it does not appear to alter the outcome of other glomerulopathies.
Area of Science:
- Nephrology
- Pathology
- Genetics
Background:
- Thin basement membrane nephropathy (TBMN) is frequently reported alongside various glomerular diseases.
- The co-occurrence raises questions about potential pathogenetic links versus coincidental associations.
Purpose of the Study:
- To explore the relationship between TBMN and other glomerular diseases.
- To investigate the prognostic implications of co-existing glomerulopathies in TBMN patients.
Main Methods:
- Review of existing clinical and pathological reports on TBMN and associated glomerular diseases.
- Analysis of clinical evidence regarding prognosis in patients with combined conditions.
Main Results:
- Associations with minimal change glomerulonephritis, diabetes, and membranous nephropathy are likely artifactual or coincidental.
- A potential pathogenetic link exists between TBMN and IgA glomerulonephritis and focal segmental glomerulosclerosis.
- Associated glomerulopathies significantly worsen TBMN prognosis, leading to increased proteinuria, hypertension, and renal insufficiency.
- TBMN does not appear to alter the prognosis of other glomerulopathies, including IgA disease.
Conclusions:
- Renal biopsy is recommended for TBMN suspects with heavy proteinuria or renal insufficiency to identify co-existing glomerulopathies.
- While TBMN impacts its own prognosis when combined with other diseases, it does not worsen the outlook for conditions like IgA disease.